In patients with stable CVD receiving statins, evolocumab reduced acute arterial events across all vascular territories.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 35100002.
- Also identified by DOI 10.7326/J21-0013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oyama K, Giugliano RP, Tang M, et al. <b>Effect of evolocumab on acute arterial events across all vascular territories: results from the FOURIER trial.</b> Eur Heart J. 2021;42:4821-9. 34537830.
Medical subject headings
- Anticholesteremic Agents
- Cardiovascular Diseases
- Hydroxymethylglutaryl-CoA Reductase Inhibitors